Chronic lymphocytic leukaemia-associated insect bite-like reaction responding to ibrutinib, an immunomodulatory Bruton tyrosine kinase inhibitor

Clin Exp Dermatol. 2021 Dec;46(8):1569-1571. doi: 10.1111/ced.14761. Epub 2021 Jun 22.

Authors

M Wimalachandra¹, T N Basu², J Salisbury³, N Attard⁴, E Calonje⁴, P E M Patten^{1

5}

Affiliations

¹ Department of, Haematological Medicine, King's College Hospital, London, UK.
² Department of, Dermatology, King's College Hospital, London, UK.
³ Department of, Histopathology, King's College Hospital, London, UK.
⁴ St John's Institute of Dermatology, Guy's and St Thomas' Hospital, London, UK.
⁵ School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College Hospital, London, UK.

PMID: 34028865
DOI: 10.1111/ced.14761

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adenine / analogs & derivatives*
Adenine / therapeutic use
Agammaglobulinaemia Tyrosine Kinase / antagonists & inhibitors*
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / complications*
Male
Middle Aged
Piperidines / therapeutic use*
Protein Kinase Inhibitors / therapeutic use*
Skin / pathology*
Skin Diseases / drug therapy*
Skin Diseases / etiology

Substances

Piperidines
Protein Kinase Inhibitors
ibrutinib
Agammaglobulinaemia Tyrosine Kinase
Adenine